A Phase 2 Open-label Study to Evaluate the Activity of Etavopivat on Transcranial Doppler Velocities in Pediatric Patients With Sickle Cell Disease Who Are at Increased Risk for Primary Stroke | MicrobiomeTrials
A Phase 2 Open-label Study to Evaluate the Activity of Etavopivat on Transcranial Doppler Velocities in Pediatric Patients With Sickle Cell Disease Who Are at Increased Risk for Primary Stroke
RecruitingPHASE2INTERVENTIONAL
Trial Details
Start: 2023-06-20Est. Completion: 2027-08-20
Enrollment target: 27 participants
Locations
All India Institute of Medical Sciences (AIIMS), Raipur, Raipur, Chhattisgarh, India
All India Institute of Medical Sciences-Delhi, Delhi, India
Nirmal Hospital Pvt. Ltd., Gujarat, India
Suretech Hospital and Research Centre Ltd., Maharashtra, India
Indira Gandhi Government Medical College & Hospital, Nagpur, India
University College Hospital (UCH), Ibadan, Oyo State, Nigeria
Lagos University Teaching Hospital, Lagos, Lagos, Nigeria